ADORA3 and breast carcinoma: The expression signature combining these 25 genes exhibited a strong correlation with the 3-gene ENTPD1/NT5E/ADORA3 signature in ER+ breast cancers in the TCGA BRCA cohort, and this relationship is also observed with each of the three genes individually (Figure 2A).